Lee, E. Y. H. P., & Muller, W. J. (2010). Oncogenes and tumor suppressor genes. Cold Spring Harbor Perspectives in Biology, 2, a003236–a003236. https://doi.org/10.1101/cshperspect.a003236

Article  PubMed  PubMed Central  Google Scholar 

Zhu, L., Jiang, M., Wang, H., et al. (2021). A narrative review of tumor heterogeneity and challenges to tumor drug therapy. Annual Translational Medicine, 9, 1351. https://doi.org/10.21037/atm-21-1948

Article  Google Scholar 

El-Sayes, N., Vito, A., & Mossman, K. (2021). Tumor heterogeneity: A great barrier in the age of cancer immunotherapy. Cancers (Basel), 13, 806. https://doi.org/10.3390/cancers13040806

Article  PubMed  Google Scholar 

Biswas, A., & De, S. (2021). Drivers of dynamic intratumor heterogeneity and phenotypic plasticity. American Journal of Physiology-Cell Physiology, 320, C750–C760. https://doi.org/10.1152/ajpcell.00575.2020

Article  PubMed  PubMed Central  Google Scholar 

Zelezníková, T., & Babusíková, O. (2006). The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia. Neoplasma, 53, 500–506.

PubMed  Google Scholar 

Patra, S., Elahi, N., Armorer, A., et al. (2021). Mechanisms governing metabolic heterogeneity in breast cancer and other tumors. Frontiers in Oncology, 11, 700629. https://doi.org/10.3389/fonc.2021.700629

Article  PubMed  PubMed Central  Google Scholar 

Sengupta, D., & Pratx, G. (2016). Imaging metabolic heterogeneity in cancer. Molecular Cancer, 15, 4. https://doi.org/10.1186/s12943-015-0481-3

Article  PubMed  PubMed Central  Google Scholar 

Moldogazieva, N. T., Mokhosoev, I. M., & Terentiev, A. A. (2020). Metabolic heterogeneity of cancer cells: An interplay between HIF-1, GLUTs, and AMPK. Cancers (Basel), 12, 862. https://doi.org/10.3390/cancers12040862

Article  PubMed  Google Scholar 

Guo, M., Peng, Y., Gao, A., et al. (2019). Epigenetic heterogeneity in cancer. Biomarker Research, 7, 23. https://doi.org/10.1186/s40364-019-0174-y

Article  PubMed  PubMed Central  Google Scholar 

Fisher, R., Pusztai, L., & Swanton, C. (2013). Cancer heterogeneity: Implications for targeted therapeutics. British Journal of Cancer, 108, 479–485. https://doi.org/10.1038/bjc.2012.581

Article  PubMed  PubMed Central  Google Scholar 

Cyll, K., Ersvær, E., Vlatkovic, L., et al. (2017). Tumour heterogeneity poses a significant challenge to cancer biomarker research. British Journal of Cancer, 117, 367–375. https://doi.org/10.1038/bjc.2017.171

Article  PubMed  PubMed Central  Google Scholar 

Heppner, G. H., & Miller, B. E. (1983). Tumor heterogeneity: Biological implications and therapeutic consequences. CANCER AND METASTASIS REVIEW, 2, 5–23. https://doi.org/10.1007/BF00046903

Article  Google Scholar 

Janku, F. (2014). Tumor heterogeneity in the clinic: Is it a real problem? Therapeutic Advances Medicine Oncology, 6, 43–51. https://doi.org/10.1177/1758834013517414

Article  Google Scholar 

Byroju, V. V., Nadukkandy, A. S., Cordani, M., & Kumar, L. D. (2023). Retinoblastoma: Present scenario and future challenges. Cell Communication and Signaling, 21, 226. https://doi.org/10.1186/s12964-023-01223-z

Article  PubMed  PubMed Central  Google Scholar 

Kawamura, S., & Tachibanaki, S. (2008). Rod and cone photoreceptors: Molecular basis of the difference in their physiology. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 150, 369–377. https://doi.org/10.1016/j.cbpa.2008.04.600

Article  Google Scholar 

Molday, R. S., & Moritz, O. L. (2015). Photoreceptors at a glance. Journal of Cell Science, 128, 4039–4045. https://doi.org/10.1242/jcs.175687

Article  PubMed  PubMed Central  Google Scholar 

Gupta, A. K., & Meena, J. P. (2020). A narrative review of retinoblastoma and recent advances in its management. Pediatric Medicine, 3, 20. https://doi.org/10.21037/pm-20-79

Article  Google Scholar 

Mendoza, P. R., Grossniklaus, H. E. (2015). The biology of retinoblastoma. Progress in Molecular Biology and Translational Science. Elsevier, pp. 503–516.

Jain, M., Rojanaporn, D., Chawla, B., et al. (2019). Retinoblastoma in Asia. Eye (London, England), 33, 87–96. https://doi.org/10.1038/s41433-018-0244-7

Article  PubMed  Google Scholar 

Finger, P. T., & Tomar, A. S. (2022). Retinoblastoma outcomes: A global perspective. The Lancet Global Health, 10, e307–e308. https://doi.org/10.1016/S2214-109X(21)00598-2

Article  PubMed  Google Scholar 

Gupta, N., Pandey, A., Dimri, K., & Prinja, S. (2020). Epidemiological profile of retinoblastoma in North India: Implications for primary care and family physicians. J Family Med Prim Care, 9, 2843. https://doi.org/10.4103/JFMPC.JFMPC_265_20

Article  PubMed  PubMed Central  Google Scholar 

Dimaras, H., Corson, T. W., Cobrinik, D., et al. (2015). Retinoblastoma. Nature Reviews Disease Primers, 1, 1–23. https://doi.org/10.1038/nrdp.2015.21

Article  Google Scholar 

Burges, M., Qaddoumi, I., Brennan, R. C., et al. (2020). Assessment of retinoblastoma capacity in the Middle East, North Africa, and West Asia Region. JCO Global Oncology, pp. 1531–1539. https://doi.org/10.1200/GO.20.00321

Fabian, I. D., Abdallah, E., Abdullahi, S. U., et al. (2022). The Global Retinoblastoma Outcome Study: A prospective, cluster-based analysis of 4064 patients from 149 countries. The Lancet Global Health, 10, e1128–e1140. https://doi.org/10.1016/S2214-109X(22)00250-9

Article  Google Scholar 

Kaliki, S., Patel, A., Iram, S., et al. (2019). Retinoblastoma in India: Clinical presentation and outcome in 1,457 patients (2,074 Eyes). Retina, 39, 379–391. https://doi.org/10.1097/IAE.0000000000001962

Article  PubMed  Google Scholar 

Kakarala, C. L., Raval, V. R., Mallu, A., et al. (2023). Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes. Oman Journal Ophthalmology, 16, 524–528. https://doi.org/10.4103/ojo.ojo_176_22

Article  Google Scholar 

Berry, J. L., Kogachi, K., Murphree, A. L., et al. (2019). A review of recurrent retinoblastoma: Children’s Hospital Los Angeles Classification and Treatment Guidelines. International Ophthalmology Clinics, 59, 65–75. https://doi.org/10.1097/IIO.0000000000000269

Article  PubMed  PubMed Central  Google Scholar 

Knudson, A. G. (1971). Mutation and cancer: Statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America, 68, 820–823. https://doi.org/10.1073/pnas.68.4.820

Article  PubMed  PubMed Central  Google Scholar 

Friend, S. H., Bernards, R., Rogelj, S., et al. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature, 323, 643–646. https://doi.org/10.1038/323643a0

Article  PubMed  Google Scholar 

Choy, K. W., Pang, C. P., Yu, C. B. O., et al. (2002). Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma. Human Mutation, 20, 408. https://doi.org/10.1002/humu.9077

Article  PubMed  Google Scholar 

Zhang, X. L., Fu, W. L., Zhao, H. X., et al. (2005). Molecular studies of loss of heterozygosity in Chinese sporadic retinoblastoma patients. Clinica Chimica Acta, 358, 75–80. https://doi.org/10.1016/j.cccn.2005.02.013

Article  Google Scholar 

Ramprasad, V. L., Madhavan, J., Murugan, S., et al. (2007). Retinoblastoma in India: Microsatellite analysis and its application in genetic counseling. Molecular Diagnosis & Therapy, 11, 63–70. https://doi.org/10.1007/BF03256223

Article  Google Scholar 

Marković, L., Bukovac, A., Varošanec, A. M., et al. (2023). Genetics in ophthalmology: Molecular blueprints of retinoblastoma. Human Genomics, 17, 82. https://doi.org/10.1186/s40246-023-00529-w

Article  PubMed  PubMed Central  Google Scholar 

O’Brien, J. M. (2001). Retinoblastoma: Clinical presentation and the role of neuroimaging. AJNR American Journal Neuroradiology, 22, 427–429. https://pmc.ncbi.nlm.nih.gov/articles/PMC7976830/

Kivelä, T. (1999). Trilateral retinoblastoma: A meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. Journal of Clinical Oncology, 17, 1829–1837. https://doi.org/10.1200/JCO.1999.17.6.1829

Article  PubMed